To Lower US Prices of its Injectable Wegovy Obesity Drug

finance.yahoo.com/news/novo-nordisk-nvo-lower-us-121111158.html

Novo Nordisk A/S (NYSE:NVO) is one of the Most Profitable Stocks to Buy Now. On November 17, Reuters reported that Novo Nordisk A/S (NYSE:NVO) will lower the US prices of its injectable Wegovy obesity drug.
The price reduction for injectable Wegovy follows the company’s earlier…

This story appeared on finance.yahoo.com, 2025-11-19 12:11:11.
The Entire Business World on a Single Page. Free to Use →